Global Liver Disease Diagnostics Market Overview
Diagnostics for liver illness include a variety of tests that can help determine the status of the liver. The liver aids in the distribution of blood and processes throughout the body. It also aids in the coagulation of proteins in the blood, the detoxification of harmful compounds, and the usage of supplements. Due to the existence of unique chemicals in liver cells, liver cells can execute synthetic responses. When cells die, these chemicals are released into the bloodstream, allowing for easier dissection during liver capacity testing. Infectious, immunological, genetic, and metabolic factors all have a role in the development of liver illnesses. Diseases have a variety of origins, making diagnosis difficult. As a result, multiple tests must be performed in order to accurately diagnose the disease's source. If a patient has liver disease, they may have symptoms such as fatigue, weakness, and nausea. The Liver Disease Diagnostics Market accounted for US$ 30.96 billion in 2020 and is estimated to be US$ 55.73 billion by 2030 and is anticipated to register a CAGR of 6.1%.
Global Liver Disease Diagnostics Market Dynamics
Rising prevalence of acute and chronic liver illness will drive the growth of the Market
One of the primary factors projected to boost the market for liver disease diagnostics is the rising prevalence of acute and chronic liver illnesses. According to the World Health Organization, 841,080 new cases of liver cancer were reported worldwide in 2018, with an estimated 781, 631 people dying from the disease. The market for liver disease diagnostics is expected to grow due to increased efforts by key companies to develop highly sensitive and quick tests to detect liver illnesses in specific populations such as pregnant women and HIV-positive individuals. For instance, Abbott got a CE mark in February 2019 for the Determine HBsAg 2 test, a sensitive, easy-to-use, and quick diagnostic test for hepatitis B. The market is expected to be driven by companies focusing on collaborations and partnerships to improve the quality of care. For example, Perspectum Diagnostics and Precious Medical Center in Singapore partnered in October 2019 to deliver LiverMultiScan. The goal of this collaboration was to raise public awareness about the importance of liver screening as part of routine health checks. Market expansion is likely to be fueled by researchers undertaking studies to promote the development of novel diagnostic methods that can accurately identify between benign and malignant tumours. For instance, Charité - Universitätsmedizin Berlin researchers employed tomoelastography to examine tumour mechanical properties and developed a new Magnetic Resonance Imaging (MRI) technique to detect tumour consistency grading.
Global Liver Disease Diagnostics Market Segmentation
Source: Prophecy Market Insights |Disclaimer: Data is only a representation. Actual data may vary in the final report.
The Global Liver Disease Diagnostics Market is segmented based on diagnosis technique, end-user and region.
On the basis of Diagnosis Technique, the Global Liver Disease Diagnostics Market is segmented into Imaging, Laboratory Tests, Endoscopy, Biopsy, Others. Based on End-User, the target market is segmented into Hospital, Laboratories, Others.
Regional Insights:
Source: Prophecy Market Insights
On region the Global Liver Disease Diagnostics Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America led the market with a revenue share of 43.1 percent, followed by Europe. The presence of prominent players and high R&D investments are projected to drive the growth of the market for liver disease diagnostics in the region. Furthermore, the presence of organisations that supply patients with information about disease diagnosis is projected to drive the market for liver disease diagnostics forward. GetPalliativeCare.org is one such group that gives palliative care information on diagnostic modalities such as endoscopy, CT scan, and biopsy. During the projected period, the market for liver disease diagnostics in Asia Pacific is expected to rise at a substantial rate. The expansion of the market for liver disease diagnostics in this region is being fueled by an ageing population and increased awareness of the importance of regular check-ups. Furthermore, regional growth is expected to be fueled by regulatory approval of sophisticated technologies that can be combined with imaging systems. For example, the Therapeutic Goods Administration (TGA) approved LiverMultiScan in August 2018 to detect individuals with extremely prevalent illnesses in Australia, such as NAFLD and NASH.
Report Scope:
|
Attribute |
Details |
|
Base year for estimation |
2020 |
|
Forecast period |
2020 – 2030 |
|
Market representation |
Revenue in USD Million & CAGR from 2020 – 2029 |
|
Market Segmentation |
By Diagnosis Technique- Imaging, Laboratory Tests, Endoscopy, Biopsy, Others By End-User– Hospital, Laboratories and Others |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the Global Liver Disease Diagnostics Market report based on Diagnosis Technique, End-User and region.
Global Liver Disease Diagnostics Market, By Region:
-
-
- North America
-
- U.S.
- Canada
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- North America
-
Global Liver Disease Diagnostics Market Key Players
The key players operating in the liver disease diagnostics market are Abbott, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Randox Laboratories Ltd., Boston Scientific Corporation, Laboratory Corporation of America Holdings, Fujifilm Corporation, Horiba Medical and Siemens Healthcare GmbH. Multiple strategies for the development of novel technologies to advance patient care are being implemented by the key players. BTG plc was acquired by Boston Scientific Corporation in August 2019 to provide access to sophisticated technology for better patient care.
Global Liver Disease Diagnostics Market Company Profile
- Abbott
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- F. Hoffmann-La Roche Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Thermo Fisher Scientific Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Randox Laboratories Ltd.,
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Laboratory Corporation of America Holdings
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Fujifilm Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Horiba Medical
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Siemens Healthcare GmbH
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
Global Liver Disease Diagnostics Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for Liver Disease Diagnostics Strategies
- Key Questions this Study will Answer
- Market Snippet, By Diagnosis Technique
- Market Snippet, By End-User
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global Liver Disease Diagnostics Market, By Diagnosis Technique, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Imaging
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Laboratory Tests
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Endoscopy
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Biopsy
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Liver Disease Diagnostics Market, By End-User, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Hospital
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Laboratories
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Liver Disease Diagnostics Market, By Region, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Diagnosis Technique, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Diagnosis Technique, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Diagnosis Technique, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Diagnosis Technique, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Diagnosis Technique, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- Abbott
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- F. Hoffmann-La Roche Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Thermo Fisher Scientific Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Randox Laboratories Ltd.,
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Laboratory Corporation of America Holdings
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Fujifilm Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Horiba Medical
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Siemens Healthcare GmbH
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
Global Liver Disease Diagnostics Market is segmented based on diagnosis technique, end-user and region.
Rising prevalence of acute and chronic liver illness is major factor driving the market.
During the forecast period, North America is expected to dominate the market.
The key players operating in the liver disease diagnostics market are Abbott, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Randox Laboratories Ltd., Boston Scientific Corporation, Laboratory Corporation of America Holdings, Fujifilm Corporation, Horiba Medical and Siemens Healthcare GmbH.